1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) network is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), NIH. The ReVAMPP network will research pathogens that currently lack effective treatments and vaccines, with the NIH's National Institute of Allergy and Infectious Diseases (NIAID) committing up to $100 million per year to the effort.
It focuses on virus families with known troublemakers, including those that cause dengue and yellow fever, measles, polio, and chikungunya. The agency says that focusing on representative pathogens known to cause human disease will enable knowledge to be built that can be transferred to related pathogens.
Developing new antibodies and vaccines for these diseases will allow the global health community to respond quickly if a new pandemic threat spawns.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Recipients of previous funding include the Albert Einstein College of Medicine, the Research Triangle Institute in North Carolina, the Vanderbilt University Medical Center, and Washington University in St. Louis, among others. Universities are eligible. Confirm the full requirements in the official notice before applying.
The current listing shows up to $100,000,000 per year. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) network is funded by National Institute of Allergy and Infectious Diseases (NIAID), NIH. Verify program details on the funder's official page before applying.
This opportunity targets applicants in North Carolina and Washington. Check the official notice for exact location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
National Institute of Allergy and Infectious Diseases (NIAID) Resource-Related Research Projects (R24 Clinical Trial Not Allowed) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), NIH. This program supports resource development projects to advance infectious disease and immunology research, aligning with NIAID's vision to improve human health through an integrated approach to infectious and immune-mediated disease research.
National Institute of Allergy and Infectious Diseases (NIAID) Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), NIH. This funding opportunity supports investigator-initiated clinical trials requiring enhanced oversight, with durations up to 7 years, relevant to the NIAID mission of improving human health through infectious and immune-mediated disease research.
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articlePAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read article